SCR-LIP-000480 · Claim · machine-readable JSON →
A narrative review reports that ketogenic/low-carbohydrate diets in women with lipedema reduce insulin resistance (lower HOMA-IR and basal insulin), promote weight loss (cited meta-analysis: BMI reduction of 4.23 kg/m² and 7.94 kg over ~15.85 weeks), and a controlled study showed low-carb diet significantly reduced calf subcutaneous adipose tissue area and pain (NRS), though the authors note data are limited and long-term studies are needed.
This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 0 question(s)
- Dates
- 2026-11-17 → 2026-11-17
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17
Evidence over time
Evidence (1)
- Therapeutic Applications of Ketogenic Diets in Lipedema: A Narrative Review of Current Evidence (2025) ✓ verified — consistent · review · 2025 · reading confidence: high
“Estudo controlado: dieta low-carb reduziu significativamente área de SAT (subcutaneous adipose tissue) na panturrilha e dor (NRS)”
The review synthesizes evidence (including a cited meta-analysis and a controlled study) concluding ketogenic diets are a promising therapeutic option for lipedema, reducing pain, inflammation, and improving body composition, while cautioni
Context (PECO)
Answers these questions
- Not yet linked to a question.
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-11-17 — created · auto-ingested for SQ-LIP-000014
- 2026-11-20 — consolidated · SQ-LIP-000014: evidence moved to SCR-LIP-000659